Related Experiment Videos
Current treatment for chronic arthritis in childhood
1The Children's Hospital of Philadelphia. University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4318, USA. rqcron@mail.med.upenn.edu
Insights
Treatment for childhood chronic arthritis is advancing rapidly. Key treatments include nonsteroidal anti-inflammatory drugs, methotrexate, and corticosteroid injections, with newer biologic therapies offering improved disease control.
Area of Science:
- Pediatric Rheumatology
- Immunology
Background:
- Chronic arthritis in children presents significant management challenges.
- Traditional treatments have limitations in achieving long-term disease control.
Purpose of the Study:
- To review current and emerging treatment strategies for chronic arthritis in children.
- To highlight advancements in disease management and future therapeutic directions.
Main Methods:
- Review of current literature on pediatric chronic arthritis treatments.
- Analysis of the efficacy of nonsteroidal anti-inflammatory drugs, methotrexate, and corticosteroid injections.
- Evaluation of the impact of tumor necrosis factor inhibitors and emerging biologic therapies.
Main Results:
- Nonsteroidal anti-inflammatory drugs are foundational, but methotrexate and intra-articular corticosteroids significantly improve disease control.
- Tumor necrosis factor inhibitors have demonstrated substantial efficacy in managing disease activity.
- Aggressive therapies are reserved for refractory cases, with promising targeted biologic treatments on the horizon.
Conclusions:
- Significant progress has been made in treating chronic arthritis in children.
- The advent of targeted biologic therapies offers a brighter future for affected children.
- Continued research into novel treatments is crucial for optimizing pediatric arthritis management.
Abstract:
Treatment of chronic arthritis in childhood is progressing quickly. Nonsteroidal antiinflammatory drugs still remain mainstays of treatment, but weekly methotrexate and intra-articular corticosteroid injections have made the biggest impact on disease control. Recently, tumor necrosis factor inhibitors have become available for the treatment of chronic childhood arthritis and have already had a substantial influence on disease activity. Very aggressive measures are still reserved for the sickest children who do not respond to conventional therapy, but the future for children with chronic arthritis looks bright with newer, highly targeted biologic therapies in the pipeline.